In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii
about
In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondiiSynergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosisIn vitro and in vivo effects of doxycycline on Toxoplasma gondiiSynergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in miceEffectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeysIn vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondiiThe ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infectionPyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS.The new macrolides. Azithromycin and clarithromycin.Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.Pharmacokinetics of spiramycin in the rhesus monkey: transplacental passage and distribution in tissue in the fetus.In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondiiAzithromycin: the first azalide antibiotic.In vitro effects of three new 1,2,4-trioxanes (pentatroxane, thiahexatroxane, and hexatroxanone) on Toxoplasma gondii.In vitro and in vivo activities of macrolides against Mycobacterium lepraeToxoplasma gondii: susceptibility and development of resistance to anticoccidial drugs in vitro.Spectrum of activity of azithromycin.Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in miceComparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.New antibacterials for the treatment of toxoplasmosis; a patent review.New directions for macrolide antibiotics: structural modifications and in vitro activity.Recent developments in the prevention and treatment of congenital toxoplasmosis.Opportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis.The potential role of azithromycin in the treatment of prophylaxis of toxoplasmosis.Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.Efficacy of azithromycin in the treatment of cutaneous leishmaniasis.
P2860
Q28321674-874BA8E5-1311-449D-B46F-0BDC9DAD0EA5Q28326714-8C08128A-A6EB-40C6-AA1D-1002CFDBE221Q28335472-8C952DB8-B2C7-4220-BCDA-C32878485AFDQ28343091-DAF12681-8F41-4F62-B424-923C9A08B30FQ28368237-566E86C9-4547-4A61-814C-43FEB39FA2CFQ28378355-094A67AA-EF75-4582-8F95-C0501F39A7E2Q28379168-62DEF875-784C-4F78-B7B7-5C6DDFED646AQ33379090-D58ECB00-7057-4393-AE63-0BFE0982E701Q33607251-C69EC4B8-CE32-44FE-8DEA-BF5AD0FEA0E0Q33745394-7FC4C613-C3B6-47FF-A7C9-88ADF5A63027Q33757694-64CAE857-1607-4DC8-BA06-A58281769BCCQ35116242-B5275BEA-D1C6-4019-86B9-B7409E18AEC0Q35234822-3698A41F-4B9E-4A3B-B7B6-FD9B49DEBA77Q35354962-A8E83BFF-4508-423F-BD1C-9948CE75B1FBQ35565659-BDCBCB74-9BD9-4D0A-89E1-04901E27E261Q35899924-860374CB-4A4D-4ACB-96C8-4421D626BFDDQ36454256-F819F3F2-53AC-44A2-8746-9EB6D5460293Q36753517-CE5F5B98-2F5F-41C8-A934-6A7D4E340D40Q36753766-BFB62277-F58B-4F9A-ACA8-175EB8B0378FQ37992089-EA031F0E-FA37-45F3-B8EF-74D68CF74EB2Q38721368-94D1D9A6-82AE-4CE7-A31E-FB544277F088Q38774985-557B133D-8254-41C5-94BA-5BB686636D80Q40865388-7F4599B6-D324-4027-8BED-ED3AB7B57C67Q41000192-6FA7B4BA-5718-4107-BBEA-FB514CA861D2Q43202341-4CAA9CB0-A063-4875-BF62-A4C34005B180Q44027432-6BAE2CD9-35AE-4A1A-BAAA-0485AACCE195Q44095794-829AB863-99F6-4D79-AE93-87F3AEA29D4A
P2860
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii
description
1988 nî lūn-bûn
@nan
1988 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
In vitro effects of four macro ...... A-56268) on Toxoplasma gondii
@ast
In vitro effects of four macro ...... A-56268) on Toxoplasma gondii
@en
In vitro effects of four macro ...... A-56268) on Toxoplasma gondii
@nl
type
label
In vitro effects of four macro ...... A-56268) on Toxoplasma gondii
@ast
In vitro effects of four macro ...... A-56268) on Toxoplasma gondii
@en
In vitro effects of four macro ...... A-56268) on Toxoplasma gondii
@nl
prefLabel
In vitro effects of four macro ...... A-56268) on Toxoplasma gondii
@ast
In vitro effects of four macro ...... A-56268) on Toxoplasma gondii
@en
In vitro effects of four macro ...... A-56268) on Toxoplasma gondii
@nl
P2860
P356
P1476
In vitro effects of four macro ...... A-56268) on Toxoplasma gondii
@en
P2093
J C Pechère
P2860
P356
10.1128/AAC.32.4.524
P407
P577
1988-04-01T00:00:00Z